Prevalence of Electronic Cigarette Use Among Adolescents in New Jersey and Association With Social Factors.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
05 02 2020
Historique:
entrez: 13 2 2020
pubmed: 13 2 2020
medline: 25 8 2020
Statut: epublish

Résumé

Use of electronic cigarettes (e-cigarettes) is high among adolescents, but the extent to which the JUUL e-cigarette brand accounts for the high prevalence has not been explored using population-based surveys. To examine e-cigarette and JUUL use among adolescents in New Jersey. Survey study using data from the 2018 New Jersey Youth Tobacco Survey, a cross-sectional statewide representative survey of tobacco use. The survey was school based and sampled New Jersey students in grades 9 to 12. Use of tobacco products; JUUL as first tobacco product tried; exposure to JUUL at school; number of friends perceived as JUUL users; liking or following a tobacco brand on social media; and buying or receiving tobacco-branded merchandise. Prevalence ratio (PR) for current and frequent e-cigarette use, inclusive of JUUL. In this sample of 4183 adolescents, respondents were 49.6% female and 49.6% non-Hispanic white. Students were evenly distributed across grades 9 through 12. Overall, the estimate for current use of e-cigarettes inclusive of JUUL was higher (24.2%; 95% CI, 22.5%-25.9%) compared with current use assessed by use of e-cigarettes only (17.8%; 95% CI, 16.4%-19.4%) or JUUL use only (21.3%; 95% CI, 19.7%-23.0%). Divergence in e-cigarette use estimates was higher for certain subgroups, including female respondents and non-Hispanic black respondents. Also, 88.8% (95% CI, 86.6%-91.1%) of current e-cigarette users reported JUUL as a brand they used. Hispanic students (PR, 0.78; 95% CI, 0.69-0.89) and non-Hispanic students of other races (PR, 0.64; 95% CI, 0.51-0.81) were significantly less likely than non-Hispanic white students to be current e-cigarette users, and students in 12th grade were more likely than those in 9th grade to be current users (PR, 1.29; 95% CI, 1.11-1.48). Current e-cigarette use was positively associated with current use of other tobacco products (PR, 2.57; 95% CI, 2.24-2.95), endorsing a tobacco brand on social media (PR, 1.43; 95% CI, 1.19-1.72), having tobacco-branded merchandise (PR, 1.70; 95% CI, 1.46-1.97), having close friends who used JUUL (PR, 3.81; 95% CI, 3.17-4.58), and seeing JUUL used on school grounds (PR, 1.43; 95% CI, 1.24-1.65). Estimates of prevalence were greater when modeling frequent use. This study found that prevalence of current and frequent e-cigarette use among adolescents was higher when inclusive of JUUL use, and JUUL was by far the most common e-cigarette brand used, providing support for inclusion of brand-specific questions when assessing e-cigarette use. The results also identify characteristics of adolescents who may be more likely to use e-cigarettes.

Identifiants

pubmed: 32049291
pii: 2760662
doi: 10.1001/jamanetworkopen.2019.20961
pmc: PMC7087400
mid: NIHMS1574634
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1920961

Subventions

Organisme : NCI NIH HHS
ID : U54 CA229973
Pays : United States

Références

Am J Epidemiol. 2010 Mar 1;171(5):618-23
pubmed: 20133516
Am J Epidemiol. 2017 Aug 15;186(4):405-410
pubmed: 28369184
Drug Alcohol Depend. 2019 Nov 1;204:107512
pubmed: 31487572
MMWR Morb Mortal Wkly Rep. 2019 Feb 15;68(6):157-164
pubmed: 30763302
Tob Control. 2019 Nov;28(6):676-677
pubmed: 30194085
Am J Health Behav. 2004 Mar-Apr;28(2):173-9
pubmed: 15058518
Am J Prev Med. 2014 Aug;47(2 Suppl 1):S4-14
pubmed: 25044195
Prev Med. 2010 Nov;51(5):394-6
pubmed: 20817023
Occup Environ Med. 1998 Apr;55(4):272-7
pubmed: 9624282
MMWR Morb Mortal Wkly Rep. 2016 Dec 09;65(48):1357-1363
pubmed: 27932780
Am J Epidemiol. 1987 May;125(5):761-8
pubmed: 3551588
Tob Control. 2019 Jan;28(1):115-116
pubmed: 29669749
BMJ Open. 2019 Apr 4;9(4):e026306
pubmed: 30948599
Tob Control. 2019 Mar;28(2):146-151
pubmed: 29853561
Tob Control. 2019 Nov;28(6):603-609
pubmed: 30377241
JAMA. 2019 Sep 16;:
pubmed: 31524940
JAMA Netw Open. 2018 Oct 5;1(6):e183535
pubmed: 30646249
Health Promot Pract. 2020 Jan;21(1):20-24
pubmed: 31530185
J Adolesc Health. 2020 Jan;66(1):48-55
pubmed: 31481286
Am J Health Behav. 2019 May 1;43(3):591-605
pubmed: 31046889
Nicotine Tob Res. 2018 Oct 27;:
pubmed: 30371838
Nicotine Tob Res. 2018 Nov 5;:
pubmed: 30395344
Drug Alcohol Depend. 2019 Jan 1;194:395-400
pubmed: 30497057
MMWR Morb Mortal Wkly Rep. 2018 Nov 16;67(45):1276-1277
pubmed: 30439875
JAMA. 2019 Nov 5;:
pubmed: 31688912
J Am Coll Health. 2019 Mar 26;:1-5
pubmed: 30913003
N Engl J Med. 2019 Oct 10;381(15):1490-1491
pubmed: 31532955
Addict Behav. 2019 Aug;95:178-183
pubmed: 30933713

Auteurs

Mary Hrywna (M)

Department of Health Behavior, Society and Policy, Rutgers School of Public Health, Piscataway, New Jersey.
Rutgers Center for Tobacco Studies, New Brunswick, New Jersey.
Rutgers Cancer Institute of New Jersey, New Brunswick.

Michelle T Bover Manderski (MT)

Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, New Jersey.
Rutgers Center for Tobacco Studies, New Brunswick, New Jersey.
Rutgers Cancer Institute of New Jersey, New Brunswick.

Cristine D Delnevo (CD)

Department of Health Behavior, Society and Policy, Rutgers School of Public Health, Piscataway, New Jersey.
Rutgers Center for Tobacco Studies, New Brunswick, New Jersey.
Rutgers Cancer Institute of New Jersey, New Brunswick.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH